| book details |

A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap

By (author) Board on Health Sciences Policy, By (author) Committee on Review of NASA's Bioastronautics Roadmap, By (author) National Research Council, By (author) Aeronautics and Space Engineering Board, By (author) Space Studies Board, By (author) Institute of Medicine, By (author) National Academy of Sciences, Edited by David E. Longnecker, Edited by Ricardo A. Molins, Edited by R. A. Molins

| on special |

normal price: R 1,853.95

Price: R 1,760.95

| add to trolley |

| book description |

Extending the spatial and temporal boundaries of human space flight is an important goal for the nation and for the National Aeronautics and Space Administration (NASA). However, human space flight remains an endeavor with substantial risks, and these risks must be identified, managed, and mitigated appropriately to achieve the nation's goals in space. The Bioastronautics Roadmap (BR) is the result of extensive, commendable efforts on the part of NASA to prioritize research efforts to meet these challenges. In 2003, NASA asked the Institute of Medicine (IOM), in collaboration with the Division on Engineering and Physical Sciences of the National Academies, to conduct a review of the BR. Specifically, NASA asked the committee to (1) conduct a comprehensive assessment and report of the strengths and weaknesses of the content and processes of the Bioastronautics Roadmap as applied to the missions described in the President's exploration initiative and (2) identify the unique challenges for accomplishing its goals and objectives. In September 2004, the committee released its preliminary report to NASA entitled Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap. That document presented the committee's preliminary conclusions about the strengths and weaknesses of the April 2004 version of the BR. This report, A Risk Reductions Strategy for Human Exploration of Space, builds on those preliminary conclusions and provides recommendations to NASA about how to address the issues identified by the committee.

| product details |

| other options |

Normally shipped | Usually dispatched in 3 to 4 weeks as supplier is out of stock
Readership Age |

Normal Price | R 2,181.95
Price | R 2,072.95 | on special |

| add to trolley |

| back |

| your trolley |

To view the items in your trolley please sign in.

| sign in |

| specials |

The Silent Patient: The record-breaking, multimillion copy Sunday Times bestselling thriller and TikTok sensation

Alex Michaelides
Paperback / softback
352 pages
was: R 280.95
now: R 252.95
Available from overseas. Dispatched in aprox 4-8 weeks as local supplier is out of stock

With film rights snapped up by an Oscar winning Hollywood production company, rights sold in a world record 43 territories, and rave blurbs from David Baldacci, Lee Child and A.

| more |

| add to trolley |

The Thing at 52

Mr. Ross Montgomery
Hardback
40 pages
was: R 363.95
now: R 345.95
Usually dispatched in 3 to 4 weeks as supplier is out of stock

The Thing at 52 is aÂ beautiful picture book about friendship, loneliness and learning how to say goodbye.

| more |

| add to trolley |

Free Your Mind: The new world of manipulation and how to resist it

Laura Dodsworth
Paperback / softback
384 pages
was: R 300.95
now: R 270.95
Available from overseas. Dispatched in aprox 4-8 weeks as local supplier is out of stock

The Instant Sunday Times Bestseller Learn how to recognise and resist the daily attempts to control and manipulate your mind.

| more |

| add to trolley |